Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Post by bball67on Aug 08, 2021 12:41pm
246 Views
Post# 33669540

New Corporate Update

New Corporate UpdateJust finished reviewing the August 8, 2021 Corporate update. Wow! This is the best and most comprehensive document I have seen from Promis, not even close. The detail is amazing. I have a renewed sense of confidence in this Company. Been a stockholder for four years and am at 1.2M shares. This is no $75M market cap company, what a joke. This company is worth Billions. The proprietary platform and intelectual property alone is worth Billions. I sense we have a new market maker and buyers of this stock that have been steadily pushing this up in the last week coupled with subdued selling. Hopefully the old routine of a market maker shorting this stock down over and over again is over. I hope we have a break out week. 
<< Previous
Bullboard Posts
Next >>